EZZ Life Science Holdings Limited (ASX:EZZ)
Australia
· Delayed Price · Currency is AUD 1.045
+0.015 (1.46%)
Mar 10, 2026, 10:01 AM AEST
EZZ Life Science Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Operating Revenue | 61.4 | 66.87 | 66.44 | 37.14 | 15.02 | 22.29 | Upgrade
|
| Revenue | 61.4 | 66.87 | 66.44 | 37.14 | 15.02 | 22.29 | Upgrade
|
| Revenue Growth (YoY) | -18.17% | 0.65% | 78.88% | 147.26% | -32.60% | 24.03% | Upgrade
|
| Cost of Revenue | 16.78 | 17.15 | 15.5 | 8.61 | 7.51 | 9.83 | Upgrade
|
| Gross Profit | 44.62 | 49.72 | 50.95 | 28.53 | 7.51 | 12.46 | Upgrade
|
| Selling, General & Admin | 33.13 | 35.87 | 38.49 | 21.7 | 4.14 | 8.68 | Upgrade
|
| Other Operating Expenses | 4.85 | 3.41 | 2.35 | 2.03 | 1.46 | 0.9 | Upgrade
|
| Operating Expenses | 39.36 | 39.79 | 41.23 | 23.91 | 5.72 | 9.71 | Upgrade
|
| Operating Income | 5.26 | 9.93 | 9.72 | 4.62 | 1.78 | 2.75 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.02 | -0.01 | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.39 | 0.42 | 0.2 | 0.04 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.24 | 0.24 | 0.07 | 0.22 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.03 | - | 0.04 | - | - | Upgrade
|
| Pretax Income | 5.88 | 10.59 | 9.96 | 4.9 | 1.78 | 2.74 | Upgrade
|
| Income Tax Expense | 2.99 | 3.86 | 2.99 | 1.27 | 0.47 | 0.71 | Upgrade
|
| Net Income | 2.89 | 6.73 | 6.96 | 3.63 | 1.31 | 2.03 | Upgrade
|
| Net Income to Common | 2.89 | 6.73 | 6.96 | 3.63 | 1.31 | 2.03 | Upgrade
|
| Net Income Growth | -67.94% | -3.36% | 91.87% | 176.57% | -35.37% | 28.02% | Upgrade
|
| Shares Outstanding (Basic) | 47 | 46 | 43 | 43 | 43 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 46 | 43 | 43 | 43 | 34 | Upgrade
|
| Shares Change (YoY) | 6.31% | 7.35% | 0.89% | 0.46% | 25.23% | 13.15% | Upgrade
|
| EPS (Basic) | 0.06 | 0.15 | 0.16 | 0.08 | 0.03 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.06 | 0.15 | 0.16 | 0.08 | 0.03 | 0.06 | Upgrade
|
| EPS Growth | -69.86% | -9.99% | 90.19% | 175.31% | -48.37% | 13.10% | Upgrade
|
| Free Cash Flow | -2.69 | 4.13 | 5.73 | 3.91 | 1.9 | 0.25 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | 0.09 | 0.13 | 0.09 | 0.04 | 0.01 | Upgrade
|
| Dividend Per Share | 0.040 | 0.040 | 0.035 | 0.020 | 0.004 | 0.004 | Upgrade
|
| Dividend Growth | 100.00% | 14.29% | 76.77% | 340.00% | - | - | Upgrade
|
| Gross Margin | 72.67% | 74.35% | 76.68% | 76.81% | 49.98% | 55.90% | Upgrade
|
| Operating Margin | 8.56% | 14.85% | 14.62% | 12.43% | 11.88% | 12.33% | Upgrade
|
| Profit Margin | 4.71% | 10.06% | 10.48% | 9.77% | 8.74% | 9.11% | Upgrade
|
| Free Cash Flow Margin | -4.38% | 6.17% | 8.63% | 10.53% | 12.62% | 1.11% | Upgrade
|
| EBITDA | 5.42 | 10.08 | 9.75 | 4.63 | 1.8 | 2.76 | Upgrade
|
| EBITDA Margin | 8.82% | 15.08% | 14.68% | 12.48% | 11.98% | 12.41% | Upgrade
|
| D&A For EBITDA | 0.16 | 0.15 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
| EBIT | 5.26 | 9.93 | 9.72 | 4.62 | 1.78 | 2.75 | Upgrade
|
| EBIT Margin | 8.56% | 14.85% | 14.62% | 12.43% | 11.88% | 12.33% | Upgrade
|
| Effective Tax Rate | 50.86% | 36.42% | 30.07% | 25.93% | 26.26% | 25.80% | Upgrade
|
| Advertising Expenses | - | 32.27 | 37.23 | 20.56 | 2.97 | 7.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.